Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,385.00 DKK | +0.04% |
|
-1.77% | -7.20% |
01-31 | Genmab and Pfizer receive positive opinion on Tidvak | FW |
01-24 | Goldman Sachs lowers target price for Genmab to DKK 2,066 (2,425), reiterates neutral - BN | FW |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
GENMAB A/S | Bio Therapeutic Drugs | +0.04% | -1.77% | -7.20% | -28.77% | -15.39% | 12.23B | Bearish | Bearish | Bearish |
Technical Rankings Surperformance
- Stock Market
- Equities
- GMAB Stock
- Charts Genmab A/S
- Comparison Chart

MarketScreener is also available in this country: United States.
Switch edition